All Stories

  1. Sodium-glucose cotransporter 2 inhibitors for wild-type transthyretin amyloidosis: Insights from a global database
  2. Predictors of death without prior appropriate therapy in ICD recipients: the comorbidities, frailty and functional status (COMFFORT study)
  3. “Real‐world” performance of the Confirm Rx™ SharpSense AF detection algorithm: UK Confirm Rx study
  4. Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network
  5. Do co-morbidities, frailty and functional status identify patients who may not benefit from ICD therapy?
  6. Feasibility of novel unshielded portable magnetocardiography: Insights from the prospective multicenter MAGNETO-SCD trial
  7. Time to revisit combination loop and thiazide diuretic therapy for patients with acute heart failure
  8. Dual-processing theory helps to explain delay in diagnosis of Stanford type A aortic dissection
  9. Personalized subcutaneous implantable cardioverter-defibrillator sensing vectors generated by mathematical rotation increase device eligibility whilst preserving device performance
  10. Management of hyperlipidaemia following acute coronary syndrome: a retrospective audit
  11. Experiences of Temporary Transvenous Pacing in the South West of England vs the US National Inpatient Sample
  12. The permanent decline of temporary pacing
  13. Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial: comment
  14. Reconstruction of an 8-lead surface ECG from two subcutaneous ICD vectors
  15. Electrode positions, transformation coordinates for ECG reconstruction from S-ICD vectors
  16. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians
  17. Successful transvenous cardiac resynchronisation therapy in a case of coronary sinus ostial atresia
  18. ECG predictors of T wave oversensing in subcutaneous implantable cardioverter defibrillators
  19. Increasing age does not affect time to appropriate therapy in primary prevention ICD/CRT-D: a competing risks analysis
  20. “Leadless” pacing of the left ventricle in adult congenital heart disease
  21. Left and Right Parasternal Sensing for the S‐ICD in Adult Congenital Heart Disease Patients and Normal Controls
  22. Leadless pacing: The old with the new
  23. Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool
  24. Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?
  25. Comment on the article by Barraet al.entitled ‘Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations’: Figure 1
  26. Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping
  27. Strategies to reduce infections during the cardiac implantable electronic device implant: a time to name and shame
  28. Implantable Cardioverter Defibrillators in Octogenarians: Clinical Outcomes From a Single Center
  29. Oversensing and Shock Delivery in the S‐ICD: Five Shocks Two Mechanisms
  30. Letter to the Editor Regarding Survival in Octogenarians Undergoing Cardiac Resynchronization Therapy Compared to the General Population
  31. Long-term follow-up of right ventricular disarticulation for treatment of Arrhythmogenic Right Ventricular Cardiomyopathy: A case series
  32. Screening for atrial fibrillation in patients with obstructive sleep apnoea to reduce ischaemic strokes
  33. Geographic, Ethnic and Socioeconomic Factors Influencing Access to Implantable Cardioverter Defibrillators (ICDs) in New Zealand
  34. Implantable cardioverter-defibrillators: a long-term view
  35. To the Editor